almotriptan has been researched along with colforsin in 1 studies
| Studies (almotriptan) | Trials (almotriptan) | Recent Studies (post-2010) (almotriptan) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
|---|---|---|---|---|---|
| 188 | 59 | 42 | 13,460 | 46 | 1,298 |
| Protein | Taxonomy | almotriptan (IC50) | colforsin (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
| Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beleta, J; Bou, J; Domènech, T; Fernández-Forner, D; Gras, J; Heredia, A; Palacios, JM; Puig, J | 1 |
1 other study(ies) available for almotriptan and colforsin
| Article | Year |
|---|---|
Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine.
Topics: Animals; Cattle; Colforsin; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; HeLa Cells; Humans; Indoles; Male; Meningeal Arteries; Migraine Disorders; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Wistar; Saphenous Vein; Serotonin Receptor Agonists; Sumatriptan; Swine; Transfection; Tryptamines; Vasoconstriction; Vasoconstrictor Agents | 2000 |